Adam Simpson
About
Adam Simpson is from United States. Adam works in the following industries: "Biotechnology Research". Adam is currently Chief Executive Officer & Co-Founder at Icosavax, Inc.. In Adam's previous role as a President & Chief Executive Officer at PvP Biologics, Inc., Adam worked in until Jan 2020. Prior to joining PvP Biologics, Inc., Adam was a President & Chief Operating Officer at Cypher Genomics and held the position of President & Chief Operating Officer. Prior to that, Adam was a Chief Business Officer & Co-Founder at Meritage Pharma, Inc. from Jan 2008 to Jan 2012. Adam started working as General Counsel at Verus Pharmaceuticals in Jan 2005. From Jan 1999 to Jan 2005, Adam was Associate at Latham & Watkins.
Adam Simpson's contact information is available for free on finalscout.com, a web-based professional networking database with more than 500 million business contacts and 200 million company profiles.
Adam Simpson's current jobs
In-licensed self-assembling virus like particle platform for infectious disease vaccines from the Institute for Protein Design at UW and responsible for related company formation; NASDAQ: ICVX
Adam Simpson's past jobs
In-licensed celiac disease asset (now known as TAK-062) from the Institute for Protein Design at UW and responsible for related company formation; led innovative "build to buy" sale transaction with Takeda
Led all commercial and business activities for this TSRI spin-out, commencing at seed financing and culminating in the sale of Cypher to Human Longevity, Inc. (HLI)
In-licensed eosinophilic esophagitis asset (known as TAK-721) from UCSD and responsible for related company formation; led the sale of Meritage to Shire/Takeda
Led the sale of Verus to AstraZeneca and Sciele/Shionogi
In 2004, tied for the fourth highest number of IPO representations by United States lawyers, according to IPO Vital Signs